BAX and non-small cell lung carcinoma: Finally, reducing VDAC1 expression by siRNA efficiently prevented cisplatin-induced apoptosis and Bax activation in non-small cell lung cancer (NSCLC) cells 125, and inhibited selenite-induced PTP opening in HeLa cells 126.